Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Journals Home

SIGN IN

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Narrow View

NARROW

Content Type

Meeting Abstract (4)
Journal Articles (3)

Journal

Investigative Ophthalmology & Visual Science (7)

Article Type

ARVO Annual Meeting Abstract (4)
Biochemistry and Molecular Biology (3)

Topics

Biochemistry and Molecular Biology (2)
Eye Anatomy and Disorders (2)
Retina (2)
Imaging (1)
Immunology and Microbiology (1)
Pharmacology (1)
Retinal Imaging (1)
Visual Neuroscience (1)
Vitreous Disorders (1)

Tags

electroretinography (2)
peptides (2)
retina (2)
urokinase (2)
angiogenesis (1)
angiogenesis inhibitors (1)
blood-retinal barrier (1)
diabetes mellitus (1)
endothelial cells (1)
eye (1)

Specify Date Range

From: To: Apply

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

UPARANT is an effective antiangiogenic in a novel mouse model of rubeosis iridis associated with neovascular glaucoma

Helder Andre; Filippo Locri; Monica Aronsson; Maurizio Cammalleri; Massimo Dal Monte; Paola Bagnoli; Mario De Rosa; Vincenzo Pavone; Anders P Kvanta

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1251. doi:

ARVO Annual Meeting Abstract June 2017

EFFICACY OF A NEW FOOD SUPPLEMENT IN A MURINE MODEL OF ATROPHIC AMD

Dario Rusciano; Maddalena Balestra; Massimo Dal Monte; Maurizio Cammalleri; Filippo Locri; Paola Bagnoli

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1988. doi:

ARVO Annual Meeting Abstract June 2017

The Urokinase Receptor-Derived Peptide UPARANT as a novel therapy to recover high glucose-associated retinal damage in spontaneously diabetic Torii rats

Stefania Marsili; Maurizio Cammalleri; Filippo Locri; Massimo Dal Monte; Dario Rusciano; Vincenzo Pavone; Mario De Rosa; Paola Bagnoli

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5802. doi:

Biochemistry and Molecular Biology June 2017

The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood–Retinal Barrier Leakage in a Rat Model of Diabetes

PDF

Maurizio Cammalleri; Filippo Locri; Stefania Marsili; Massimo Dal Monte; Claudio Pisano; Angelo Mancinelli; Liliana Lista; Dario Rusciano; Mario De Rosa; Vincenzo Pavone; Paola Bagnoli
TAGS: diabetes mellitus, urokinase, blood-retinal barrier, electroretinography, peptides, eye, rats, retina
Invest. Ophthalmol. Vis. Sci.. 2017; 58(7):3138-3148. doi: 10.1167/iovs.17-21593

Includes: Supplemental Content

ARVO Annual Meeting Abstract September 2016

The uPAR/FPR antagonist UPARANT shows anti-angiogenic and antinflammatory properties in rodent models of retinal neovascular diseases.

Dario Rusciano; Paola Bagnoli; Helder André; Massimo Dal Monte; Maurizio Cammalleri; Filippo Locri; Monica Aronsson; Anders P Kvanta; Liliana Lista; Vincenzo Pavone; Mario De Rosa

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1114. doi:

Biochemistry and Molecular Biology May 2016

The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization

PDF

Maurizio Cammalleri; Massimo Dal Monte; Filippo Locri; Liliana Lista; Monica Aronsson; Anders Kvanta; Dario Rusciano; Mario De Rosa; Vincenzo Pavone; Helder André; Paola Bagnoli

Invest. Ophthalmol. Vis. Sci.. 2016; 57(6):2600-2611. doi: 10.1167/iovs.15-18758

Includes: Supplemental Content

Biochemistry and Molecular Biology April 2015

Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy

PDF

Massimo Dal Monte; Sara Rezzola; Maurizio Cammalleri; Mirella Belleri; Filippo Locri; Lucia Morbidelli; Michela Corsini; Giuseppe Paganini; Francesco Semeraro; Anna Cancarini; Dario Rusciano; Marco Presta; Paola Bagnoli
TAGS: angiogenesis, oxygen, vascular endothelial growth factor a, inflammatory markers, endothelial cells, urokinase, angiogenesis inhibitors, electroretinography, peptides, retinal diseases
Invest. Ophthalmol. Vis. Sci.. 2015; 56(4):2392-2407. doi: 10.1167/iovs.14-16323

Includes: Supplemental Content

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept